National Bank of Canada FI Has $79.43 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

National Bank of Canada FI trimmed its position in Colgate-Palmolive (NYSE:CL - Free Report) by 34.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 765,138 shares of the company's stock after selling 410,553 shares during the quarter. National Bank of Canada FI owned about 0.09% of Colgate-Palmolive worth $79,429,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the company. Park Avenue Securities LLC increased its position in Colgate-Palmolive by 5.0% in the 2nd quarter. Park Avenue Securities LLC now owns 7,739 shares of the company's stock worth $751,000 after buying an additional 371 shares during the period. Gateway Investment Advisers LLC grew its position in Colgate-Palmolive by 210.8% in the 2nd quarter. Gateway Investment Advisers LLC now owns 13,642 shares of the company's stock worth $1,324,000 after purchasing an additional 9,252 shares during the last quarter. MJP Associates Inc. ADV acquired a new stake in Colgate-Palmolive in the 2nd quarter worth $205,000. Czech National Bank increased its holdings in shares of Colgate-Palmolive by 7.9% during the 2nd quarter. Czech National Bank now owns 156,343 shares of the company's stock worth $15,172,000 after purchasing an additional 11,470 shares during the period. Finally, RFG Advisory LLC raised its position in shares of Colgate-Palmolive by 2.1% during the second quarter. RFG Advisory LLC now owns 5,411 shares of the company's stock valued at $525,000 after buying an additional 112 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Price Performance

Shares of NYSE:CL traded down $0.87 during midday trading on Friday, reaching $94.23. The company's stock had a trading volume of 4,104,800 shares, compared to its average volume of 4,243,885. The business's fifty day simple moving average is $96.54 and its 200-day simple moving average is $98.66. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a fifty-two week low of $75.50 and a fifty-two week high of $109.30. The company has a market capitalization of $76.99 billion, a P/E ratio of 27.00, a P/E/G ratio of 3.38 and a beta of 0.43.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.12%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive's payout ratio is presently 57.31%.

Analysts Set New Price Targets

Several brokerages recently issued reports on CL. Stifel Nicolaus lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their price target for the company from $105.00 to $101.00 in a research note on Monday, October 28th. Piper Sandler initiated coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 target price for the company. StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research note on Monday, November 25th. JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. Finally, UBS Group lifted their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of "Moderate Buy" and an average price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.